by John McMillan | Oct 23, 2026 | COVID-19
Dr. Philip McMillan, John McMillan The first head-to-head study of three mRNA vaccines in people finds the genetic cargo and its fatty packaging persisting far longer than the public was led to expect, much of it in pieces. For most of the pandemic, the reassurance...
by John McMillan | Oct 16, 2026 | COVID-19
Dr. Philip McMillan, John McMillan On paper, it should have worked. More than 17,000 adults aged 60 and over, every one of them with a past urinary tract infection, rolled up their sleeves in 20 countries for a vaccine designed to stop one of the most common causes...
by John McMillan | Oct 9, 2026 | COVID-19
Dr. Philip McMillan, John McMillan On a Friday in Siberia, a 28-year-old woman who worked at the Siberian Plague Institute died of pneumonia. Around 200 people were placed in quarantine. Reuters reported that no plague cases had been detected, and the origin of her...
by John McMillan | Oct 2, 2026 | COVID-19
Dr. Philip McMillan, John McMillan A new Science Advances paper shows the virus triggers an infected cell to make a protein that prompts nearby immune cells to build their own infection doors. An already approved drug blocked it in mice. Dr Philip McMillan argues...
by John McMillan | Sep 25, 2026 | COVID-19
Dr. Philip McMillan, John McMillan A retired German immunologist says the brain’s insulation is coming off, and a UK physician’s hospital data suggest the diseases his theory predicts are already climbing. On Sunday, September 20, at UK Column’s...
by John McMillan | Sep 18, 2026 | COVID-19
Dr. Philip McMillan, John McMillan Thousands of Canadians filed injury claims after COVID-19 vaccination, and a small fraction were approved. A retired regulator’s handwritten record of the pandemic helps explain why so many stopped trusting the system meant...
Recent Comments